Akari Therapeutics Plc
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
AKTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00972G2075
- LEI:
- Country:
- United States of America
- Address:
- 401 EAST JACKSON STREET, 33602 TAMPA
- Website:
- https://www.akaritx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Akari Therapeutics Plc is a clinical-stage oncology company focused on developing next-generation antibody-drug conjugates (ADCs) for targeted cancer therapy. The company leverages a novel discovery engine and a platform of proprietary, cancer-killing payloads to create highly specific and potent treatments. Its development strategy centers on combining these advanced payloads with antibodies to precisely target and eliminate cancer cells, aiming to improve therapeutic outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Akari Therapeutics Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Akari Therapeutics Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Akari Therapeutics Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
